- Home
- BZH vs VIR Comparison
BZH vs VIR Comparison
Compare BZH & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZH
- VIR
- Stock Information
- Founded
- BZH 1985
- VIR 2016
- Country
- BZH United States
- VIR United States
- Employees
- BZH N/A
- VIR N/A
- Industry
- BZH Homebuilding
- VIR Biotechnology: Pharmaceutical Preparations
- Sector
- BZH Consumer Discretionary
- VIR Health Care
- Exchange
- BZH Nasdaq
- VIR Nasdaq
- Market Cap
- BZH 666.1M
- VIR 706.4M
- IPO Year
- BZH 1994
- VIR 2019
- Fundamental
- Price
- BZH $24.63
- VIR $5.65
- Analyst Decision
- BZH Strong Buy
- VIR Strong Buy
- Analyst Count
- BZH 3
- VIR 8
- Target Price
- BZH $33.00
- VIR $30.25
- AVG Volume (30 Days)
- BZH 336.1K
- VIR 1.2M
- Earning Date
- BZH 07-31-2025
- VIR 08-04-2025
- Dividend Yield
- BZH N/A
- VIR N/A
- EPS Growth
- BZH N/A
- VIR N/A
- EPS
- BZH 3.10
- VIR N/A
- Revenue
- BZH $2,436,131,000.00
- VIR $20,861,000.00
- Revenue This Year
- BZH N/A
- VIR N/A
- Revenue Next Year
- BZH $15.69
- VIR $0.62
- P/E Ratio
- BZH $7.94
- VIR N/A
- Revenue Growth
- BZH 13.50
- VIR N/A
- 52 Week Low
- BZH $17.37
- VIR $4.32
- 52 Week High
- BZH $38.22
- VIR $14.45
- Technical
- Relative Strength Index (RSI)
- BZH 58.74
- VIR 54.74
- Support Level
- BZH $23.01
- VIR $5.31
- Resistance Level
- BZH $25.91
- VIR $5.92
- Average True Range (ATR)
- BZH 0.89
- VIR 0.30
- MACD
- BZH 0.05
- VIR 0.02
- Stochastic Oscillator
- BZH 61.12
- VIR 43.69
About BZH Beazer Homes USA Inc.
Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.